Latest Articles

ACC/AHA vs ESC/EAS LDL–C recommendations for residual risk reduction in ASCVD: A simulation study from Da Vinci

Relationship Between LDL-C LLTs and Risk of Stroke

Lipid-Lowering Therapy and Achievement of Lipid Targets ESC and EAS Guidelines

LDL-C The Only Causal Risk Factor for ASCVD

Why low-density lipoprotein-cholesterol, the only causal risk factor for atherosclerotic cardiovascular disease, is still overlooked and underestimated.

LDL-C Targets in Patients with Heterozygous Familial Hypercholesterolemia

LLTs Exposure Time and Major Vascular Risk Reduction

PCSK9i after hospital discharge for acute MI

LLTs and Antithrombotic Therapy in PAD

PCSK9i and Prevention of CVD

The synopsis of a Cochrane Systematic review on PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.